28 June 2022>: Clinical Research
Impact of a Rehabilitation Program on the Change in Components of Body Mass of the Upper and Lower Limbs in People After Ischemic Stroke
Grzegorz Przysada 1ACDF , Justyna Leszczak 2ABEF* , Joanna Baran 2CDE , Andżelina Wolan-Nieroda 2BDF , Bogumiła Pniak 3CDE , Viliam Knap 4BDF , Mariusz Drużbicki 2ADF , Agnieszka Guzik 2ADEDOI: 10.12659/MSM.936397
Med Sci Monit 2022; 28:e936397
Table 6 The effect of rehabilitation on the amount of fat at 2 to 3 and 4 to 6 months after stroke.
Time after stroke | Side of paresis | Exam | N | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FAT | FAT right lower limb | FAT left lower limb | FAT right arm | FAT left arm | ||||||||||||||
2–3 months | Left | Exam I | 6 | 27.59 | 3.61 | 0.072*** | 17.01 | 3.78 | 0.632*** | 13.99 | 9.03 | 0.262*** | 11.03* | 10.26–19.64* | 0.345** | 14.27 | 7.20 | 0.047*** |
Exam II | 6 | 21.62 | 9.06 | 15.55 | 7.94 | 15.12 | 8.30 | 12.78* | 9.68–17.54* | 13.59 | 7.31 | |||||||
Right | Exam I | 6 | 29.01 | 3.66 | 0.242*** | 18.69 | 3.63 | 0.856*** | 18.77 | 7.12 | 0.908*** | 14.56 | 8.41 | 0.761*** | 12.45 | 10.05 | 0.700*** | |
Exam II | 6 | 23.49 | 8.75 | 19.37 | 8.05 | 18.82 | 6.99 | 14.36 | 9.06 | 12.55 | 9.77 | |||||||
2–3 months | Left | Exam II | 6 | 21.63* | 13.25–27.56* | 0.180** | 15.55 | 7.94 | 0.746*** | 15.12 | 8.30 | 0.687*** | 14.58 | 7.08 | 0.537*** | 13.59 | 7.31 | 0.676*** |
Exam III | 6 | 21.93* | 13.25–28.40* | 17.22 | 7.79 | 17.22 | 7.58 | 11.51 | 7.92 | 11.13 | 8.99 | |||||||
Right | Exam II | 6 | 23.49 | 8.75 | 0.790*** | 19.37 | 8.05 | 0.578*** | 18.82 | 6.99 | 0.634*** | 14.36 | 9.06 | 0.881*** | 12.55 | 9.77 | 0.591*** | |
Exam III | 6 | 23.40 | 9.12 | 16.95 | 6.98 | 16.98 | 6.84 | 15.16 | 6.26 | 15.55 | 5.79 | |||||||
4–6 months | Left | Exam I | 7 | 23.78 | 5.63 | 0.323*** | 11.47 | 3.10 | 0.068*** | 17.59 | 12.92–26.67 | 0.893** | 15.22* | 10.84–16.67* | 0.225** | 15.86 | 7.36 | 0.915*** |
Exam II | 7 | 26.46 | 7.66 | 18.12 | 7.74 | 17.08 | 12.92–22.09 | 15.65* | 12.82–22.97* | 15.80 | 6.56 | |||||||
Right | Exam I | 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
Exam II | 1 | – | – | – | – | – | – | – | – | – | – | |||||||
4–6 months | Left | Exam II | 7 | 24.88* | 23.40–34.97* | 0.465** | 18.12 | 7.74 | 0.459*** | 18.18 | 7.32 | 0.365*** | 17.01 | 6.27 | 0.215*** | 15.80 | 6.56 | 0.765*** |
Exam III | 7 | 27.29* | 23.25–34.97* | 15.63 | 7.12 | 15.02 | 7.34 | 12.36 | 5.99 | 14.85 | 6.78 | |||||||
Right | Exam II | 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
Exam III | 1 | – | – | – | – | – | – | – | – | – | – | |||||||
* Median (Q1–Q3); ** Wilcoxon test; *** T-test. |